Strateos Closes $56 Million Series B Financing To Accelerate The Roll-Out Of Its Smartlab Of The Future Platform
Strateos Closes $56 Million Series B Financing To Accelerate The Roll-Out Of Its Smartlab Of The Future Platform
06/08/21, 11:12 AM
Location
menlo parkMoney raised
$56 million
Round Type
series b
Strateos, Inc., a pioneer in the development of remote access laboratories and lab control software for life science research, today announced the closing of its $56.1 million Series B financing led by DCVC and Lux Capital with participation from new investors including Eli Lilly and Company, Ally Bridge Group, Black Diamond Ventures, Mack & Co., LLC, and Castor Ventures. With this financing, Strateos will continue to drive innovations on its SmartLab PlatformTM, which integrates data generation and AI-enablement with its unique and flexible automation to accelerate pharmaceutical and synthetic biology R&D.
Company Info
Location
menlo park, california, united states
Additional Info
Strateos is a pioneer in the development of remote access laboratories and lab control software for life science discovery. Our mission is to create new knowledge driven by data, computation, automation, and high-throughput robotics with the goal of fundamentally advancing the life sciences. The Strateos SmartLab Platform™ helps scientists more efficiently and reproducibly design, run, and analyze experiments to achieve new and faster scientific discoveries. For more information, please visit www.strateos.com.